Search Results - "Martin, N.K"

A comparison of five methods to assess embolism resistance in trees by Sergent, A.S., Varela, S.A., Barigah, T.S., Badel, E., Cochard, H., Dalla-Salda, G., Delzon, S., Fernández, M.E., Guillemot, J., Gyenge, J., Lamarque, L.J., Martinez-Meier, A., Rozenberg, P., Torres-Ruiz, J.M., Martin-StPaul, N.K.

“…•Xylem embolism resistance was estimated in 11 species with contrasted wood anatomy and vessel length.•All methods tested provided consistent results in…”
Get full text

P1289 CAN COMBINATION HCV PREVENTION INTERVENTIONS IN THE DAA ERA RESULT IN DRAMATIC REDUCTIONS IN HCV PREVALENCE? A MODELING ANALYSIS IN SETTINGS WITH EXISTING HARM REDUCTION by Martin, N.K, Hickman, M, Hutchinson, S.J, Goldberg, D.J, Vickerman, P

Get full text

O90 ASSESSING THE COST-EFFECTIVENESS OF FINDING CASES OF HEPATITIS B INFECTION IN UK MIGRANT POPULATIONS by Miners, A, Martin, N.K, Ghosh, A, Hickman, M, Vickerman, P

Get full text

New Treatments for HCV: Scope for Preventing Liver Disease and HCV Transmission in England by Harris, R.J, Martin, N.K, Rand, E, Mandal, S, Mutimer, D, Ramsay, M, De Angelis, D, Hickman, M, Harris, H

Get full text

Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study by Hajarizadeh, B, Grebely, J, Byrne, M, Marks, P, Amin, J, Butler, T, Vickerman, P, Martin, N.K, Mchutchison, J.G, Brainard, D.M, Treloar, C, Lloyd, A.R, Dore, G.J

Get full text

Modelling the impact of targeted interventions on the HCV epidemic in Pakistan: the road to HCV elimination by Lim, A.G, Qureshi, H, Mahmood, H, Hamid, S, Davies, C, Trickey, A, Glass, N, Saeed, Q, Fraser, H, Walker, J.G, Mukandavire, C, Hickman, M, Martin, N.K, May, M, Averhoff, F, Vickerman, P

Get full text

Could low dead-space syringes really reduce HIV transmission to low levels? by Vickerman, P, Martin, N.K, Hickman, M

“…Abstract Studies published by Zule and colleagues have suggested that use of low dead-space syringes (LDSS) instead of high dead-space syringes (HDSS) by…”
Get full text

O124 : Is increased HCV case-finding combined with 8 or 12 week interferon-free direct-acting antiviral treatment cost-effective in UK prisons? a cost utility analysis including treatment as prevention benefits by Martin, N.K, Vickerman, P, Brew, I.F, Williamson, J, Irving, W.J, Sakshena, S, Hutchinson, S.J, Hickman, M

Get full text

Incarceration of People who inject Drugs – Modelling its Role in HCV Transmission and the Impact of Scaled-Up HCV Treatment in Prisons by Stone, J, Martin, N.K, Hickman, M, Hutchinson, S, Aspinall, E, Taylor, A, Munro, A, Dunleavy, K, Peters, E, Bramley, P, Hayes, P, Goldberg, D, Vickerman, P

Get full text

Can Targeted HCV Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Amongst Men who Have Sex with Men in the UK - Epidemiological and Modelling Insights by Martin, N.K, Thornton, A, Hickman, M, Sabin, C, Nelson, M, Cooke, G.S, Martin, T.C.S, Delpech, V, Ruf, M, Price, H, Azad, Y, Thomson, E, Vickerman, P

Get full text

Comparing Individual and Population Prevention Benefits of Early Direct-Acting Antiviral Treatment for HCV by Martin, N.K, Vickerman, P, Dore, G.J, Grebely, J, Miners, A, Cairns, J, Foster, G.R, Hutchinson, S.J, Goldberg, D.J, Martin, T.C.S, Ramsay, M, Hickman, M

Get full text

Projected impact and pathways to success of the hepatitis C virus elimination program in Georgia, 2015–2020 by Walker, J.G, Hagan, L, Fraser, H, Martin, N.K, Morgan, J, Nasrullah, M, Averhoff, F, Otiashvili, D, Chikovani, I, Aladashvili, M, Kuniholm, M.H, Kirtadze, I, Gvinjilia, L, Asatiani, A, Baliashvili, D, Khonelidze, I, Stvilia, K, Butsashvili, M, Tsertsvadze, T, Gamkrelidze, A, Kvaratskhelia, V, Vickerman, P

Get full text

979 COST-EFFECTIVENESS OF INCREASING HCV CASE-FINDING FOR PEOPLE WHO INJECT DRUGS VIA DRIED BLOOD SPOT TESTING IN ADDICTION SERVICES AND PRISONS by Martin, N.K, Hickman, M, Miners, A, Hutchinson, S.J, Taylor, A, Vickerman, P

Get full text

P1190 MODELING THE IMPACT OF EARLY ANTIRETROVIRAL THERAPY FOR ADULTS COINFECTED WITH HIV AND HEPATITIS B OR C IN SOUTH AFRICA by Martin, N.K, Devine, A, Eaton, J.W, Hallett, T.B, Foster, G.R, Dore, G.J, Easterbrook, P.J, Legood, R, Vickerman, P

Get full text

P1289 : Understanding and preventing the HCV epidemic among men who have sex with men in the UK: A mathematical modelling analysis by Martin, N.K, Hickman, M, Nelson, M, Thornton, A, Sabin, C, Lattimore, S, Martin, T.C.S, Cooke, G.S, Delpech, V, Ruf, M, Price, H, Thomson, E.C, Vickerman, P

Get full text

867 ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS by Martin, N.K, Vickerman, P, Clements, A, Cramp, M, De Angeles, D, Dillon, J.F, Fahey, S, Foster, G.R, Goldberg, D.J, Gordon, F, Hutchinson, S.J, Irving, W, Lewis, H, Ryder, S, Ustainowski, A, Vilar, J, Hickman, M

Get full text

O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study by B. Hajarizadeh, J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, N.K. Martin, J.G. McHutchison, D.M. Brainard, C. Treloar, A.R. Lloyd, G.J. Dore

Get full text

Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high‐prevalence setting? by Gountas, Ilias, Sypsa, Vana, Anagnostou, Olga, Martin, Natasha, Vickerman, Peter, Kafetzopoulos, Evangelos, Hatzakis, Angelos

“…Aims To project the impact of scaling‐up oral anti‐viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who…”
Get full text

Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA by Killion, J.A., Jegede, O.S., Werb, D., Davidson, P.J., Smith, L.R., Gaines, T., Graff Zivin, J., Zúñiga, M.L., Pines, H.A., Garfein, R.S., Strathdee, S.A., Rivera Saldana, C., Martin, N.K.

“…Supervised consumption sites (SCS) have been shown to reduce receptive syringe sharing among people who inject drugs (PWID) in the United States and elsewhere,…”
Get full text

SAT-255 - New Treatments for HCV: Scope for Preventing Liver Disease and HCV Transmission in England by Harris, R.J., Martin, N.K., Rand, E., Mandal, S., Mutimer, D., Ramsay, M., De Angelis, D., Hickman, M., Harris, H.

Get full text